a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Phase II Study to evaluate the response on two blocks of topotecan and carboplatin

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cooperative Weichteilsarkom Study Group
• Collaborator: Deutsche Krebshilfe e.V., Bonn (Germany)
• Treatments: Carboplatin; Topotecan

Criteria

Inclusion Criteria:

• Soft tissue sarcoma chemosensible, stage IV

• age < 21

• measurable tumor lesions

Exclusion Criteria:

• Lack of cooperation by the patient

• no willingness of follow-up examinations

• participation on another clinical trial at the same time

• death due to the sickness within four weeks